Grants per year
Personal profile
Research Interests
Dr. Rich has a career interest in understanding the causes and treatments of pulmonary hypertension. He was principle investigator for the NIH Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the USA for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. This knowledge has lead to the discovery of more effective treatments for pulmonary hypertension, including the use of medicines like anticoagulants, calcium channel blockers, and prostacyclins. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.
Dr. Rich is currently involved with novel drug and device development to treat advanced pulmonary hypertension and right heart failure. This includes disease modifying drugs for pulmonary arterial hypertension, a first-in-man for pulmonary hypertension associated with heart failure with preserved function, and a durable right ventricular assist device. In addition, he is a collaborator with the World Health Organization Global Burden of Disease initiative and the newly initiated pulmonary hypertension project.
He has expanded the Pulmonary Vascular Disease Program at Northwestern to now offer every approved intervention for patients, including every approved medicine, interventional procedures, surgical pulmonary endarterectomy, and lung transplantation. He also has created an alliance with the Pulmonary Hypertension Program at Lurie Children's Hospital to now offer clinical services to any patient with pulmonary hypertension of any age.
Training Experience
1976 | Internship, Washington University in St Louis, Barnes Jewish Hospital |
1978 | Residency, Washington University in St Louis, Barnes Jewish Hospital |
1980 | Fellowship, University of Chicago Hospitals |
Education/Academic qualification
MD, Loyola University/Stritch School of Medicine
… → 1974
Research interests
- Adult Congenital Heart Disease
- Cardiovascular Diseases
- Clinical Research
- Clinical Trial Methodology
- Critical Cardiac Care
- Drug Discovery
- Heart Failure
- Pulmonary Hypertension
Fingerprint
- 3 Similar Profiles
Network
Grants
-
Prot# PULSE-PAH-004: A Phase 3, Placebo Controlled, Double-blind, Randomized, Clinical Study to Determine Efficacy, Safety and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) versus Placebo in Symptomatic Subjects with Pulmonary Arterial Hypertension (
Worldwide Clinical Trials, Inc., Bellerophon Pulse Technologies LLC
11/2/16 → 11/2/19
Project: Research project
Research Output
-
Cardiac catheterization in pulmonary hypertension: doing it right, with a catheter on the left
Hansmann, G., Rich, S. & Maron, B. A., Oct 2020, In: Cardiovascular Diagnosis and Therapy. 10, 5, p. 1718-1724 7 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Dual-Energy Computed Tomography as an Alternative Noninvasive Study for Evaluation of Chronic Thromboembolic Pulmonary Hypertension Postoperatively
Desai, A., Malaisrie, S. C., Cuttica, M., Freed, B. H., Rich, S., Schimmel, D. & Avery, R., May 1 2020, In: Circulation: Cardiovascular Imaging. 13, 5Research output: Contribution to journal › Comment/debate › peer-review
-
Novel shunt modification with an adjustable stent-embedded “fenestrated” septal occluder in a patient with pulmonary hypertension
Yadlapati, A., Wax, D. F., Rich, S. & Ricciardi, M. J., Jun 1 2019, In: Catheterization and Cardiovascular Interventions. 93, 7, p. 1382-1384 3 p.Research output: Contribution to journal › Article › peer-review
-
The use of a durable right ventricular assist device for isolated right ventricular failure due to combined pre- and postcapillary pulmonary hypertension
Vullaganti, S., Tibrewala, A., Rich, J. D., Pham, D. T. & Rich, S., Apr 1 2019, In: Pulmonary Circulation. 9, 2Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Are anticoagulants still indicated in pulmonary arterial hypertension?
Olschewski, H. & Rich, S., Oct 1 2018, In: Pulmonary Circulation. 8, 4Research output: Contribution to journal › Article › peer-review
3 Scopus citations